Cost modelling-based route applicability analysis of United Kingdom passenger railway decarbonization options

被引:1
|
作者
Jiang, Kangrui [1 ]
Tian, Zhongbei [1 ]
Wen, Tao [2 ]
Hillmansen, Stuart [1 ]
Zhang, Yizhe [1 ,3 ]
机构
[1] Univ Birmingham, Sch Engn, Dept Elect Elect & Syst Engn, Birmingham B15 2TT, England
[2] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing 100044, Peoples R China
[3] ENOTRAC UK Ltd, Sutton SM1 1JB, England
基金
英国工程与自然科学研究理事会; 中国国家自然科学基金;
关键词
Railway decarbonization; Cost model; HFC trains; BEMU trains; Applicability analysis; BATTERIES;
D O I
10.1016/j.ijepes.2024.110094
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
The UK government plans to phase out pure diesel trains by 2040 and fully decarbonize railways by 2050. Hydrogen fuel cell (HFC) trains, electrified trains using pantographs (Electrified Trains), and battery electric multiple unit (BEMU) trains are considered the main solutions for decarbonizing railways. However, the range of these decarbonization options' line upgrade cost advantages is unclear. This paper analyzes the upgrade costs of three types of trains on different lines by constructing a cost model and using particle swarm optimization (PSO), including operating costs and fixed investment costs. For the case of decarbonization of the London St. Pancras to Leicester line, the electrified train option is more cost-effective than the other two options under the condition that the service period is 30 years. Then the traffic density range in which three new energy trains have cost advantages on different line lengths is calculated. For route distances under 100 km and with a traffic density of less than 52 trips/day, BEMU trains have the lowest average cost, while electrified trains are the most costeffective in other ranges. For route distances over 100 km, the average cost of HFC trains is lower than that of electrified trains at traffic densities below about 45 trips/day. In addition, if hydrogen prices fall by 26 %, the cost advantage range of HFC trains will increase to 70 trips per day. For route distances under 100 km, BEMU trains still maintain their advantages in terms of lower traffic density.
引用
收藏
页数:13
相关论文
共 20 条
  • [1] Strategic options for antenatal screening for syphilis in the United Kingdom: a cost effectiveness analysis
    Conner, N
    Roberts, J
    Nicoll, A
    JOURNAL OF MEDICAL SCREENING, 2000, 7 (01) : 7 - 13
  • [2] THE ROLE OF STRUCTURAL SENSITIVITY ANALYSIS IN THE MODELLING OF COST-EFFECTIVENESS (COST-UTILITY) IN PARKINSON'S DISEASE IN THE UNITED STATES AND UNITED KINGDOM
    Ratcliffe, A. E.
    VALUE IN HEALTH, 2012, 15 (04) : A145 - A145
  • [3] Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: A modelling-based cost-effectiveness analysis
    Wahab, Muhammad Taufeeq
    Tan, Rayner Kay Jin
    Cook, Alex R.
    Prem, Kiesha
    VACCINE, 2023, 41 (12) : 1934 - 1942
  • [4] Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom
    Max Kindred
    Zahratu Shabrina
    Neily Zakiyah
    Applied Health Economics and Health Policy, 2024, 22 : 49 - 60
  • [5] Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom
    Kindred, Max
    Shabrina, Zahratu
    Zakiyah, Neily
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024, 22 (01) : 49 - 60
  • [6] COST-EFFECTIVENESS OF PERSONALIZED NUTRITION BASED ON OMIC SCIENCES IN ADULTS WITH ABDOMINAL OVERWEIGHT OR OBESITY: A WITHIN-TRIAL ANALYSIS AND BEYOND-TRIAL MODELLING IN THE UNITED KINGDOM AND POLAND
    Galekop, M.
    Uyl-De Groot, C.
    Redekop, K.
    VALUE IN HEALTH, 2022, 25 (12) : S186 - S186
  • [7] Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis
    Gray, Ewan
    Donten, Anna
    Karssemeijer, Nico
    van Gils, Carla
    Evans, D. Gareth
    Astley, Sue
    Payne, Katherine
    VALUE IN HEALTH, 2017, 20 (08) : 1100 - 1109
  • [8] THE IMPACT OF MODELLING SUBSEQUENT TREATMENT ON ESTIMATES OF COST-EFFECTIVENESS: AN ANALYSIS OF DISEASE-MODIFYING TREATMENTS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE UNITED KINGDOM
    Phelps, H.
    Treharne, C.
    Ramirez Guevara, G.
    Bertranou, E.
    VALUE IN HEALTH, 2018, 21 : S341 - S341
  • [9] COST-UTILITY OF UNICOMPARTMENTAL COMPARED TO TOTAL KNEE REPLACEMENTS: AN ANALYSIS BASED ON MATCHED ROUTINELY-COLLECTED DATA FROM THE UNITED KINGDOM
    Burn, E.
    Liddle, A.
    Hamilton, T.
    Pandit, H.
    Murray, D.
    Judge, A.
    Pinedo-Villanueva, R.
    VALUE IN HEALTH, 2016, 19 (07) : A539 - A539
  • [10] Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial
    Blackman, Daniel J.
    Ryschon, Anne M.
    Barnett, Sophie
    Garner, Abigail M.
    Forrest, John K.
    Reardon, Michael R.
    Pietzsch, Jan B.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024,